Neoadjuvant Pembrolizumab in Cohort of Patients with dMMR/MSI Colorectal Cancer
Christelle De la Fouchardiere
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Delivered by leading experts, this series aims to provide succinct summaries of the most important study results from ESMO 2024.
The speakers and studies featured in this video series were selected independently by ESMO
Christelle De la Fouchardiere
David Tougeron
Salvatore Siena
Yelena Y. Janjigian
Peter G. de Gooyer
Maximiliano Gelli
Sara Lonardi
Francesco Sclafani
David Tougeron
Kohei Shitara
Michel P. Ducreux
Giovanni Randon
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.